Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
3(43%)
Results Posted
100%(1 trials)
Terminated
3(43%)

Phase Distribution

Ph phase_3
1
14%
Ph early_phase_1
1
14%
Ph phase_1
4
57%
Ph phase_2
1
14%

Phase Distribution

5

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(1)
Terminated(3)

Detailed Status

Terminated3
Recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
25.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (14.3%)
Phase 14 (57.1%)
Phase 21 (14.3%)
Phase 31 (14.3%)

Trials by Status

terminated343%
recruiting343%
completed114%

Recent Activity

3 active trials
Showing 5 of 7
recruitingphase_1

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

NCT05030298
recruitingphase_3

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

NCT06958328
terminatedphase_1

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

NCT03203525
recruitingphase_1

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT05092373
terminatedphase_1

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

NCT05341349
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05030298Phase 1

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Recruiting
NCT06958328Phase 3

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Recruiting
NCT03203525Phase 1

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Terminated
NCT05092373Phase 1

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Recruiting
NCT05341349Phase 1

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Terminated
NCT03477110Early Phase 1

Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma

Completed
NCT03995667Phase 2

Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer

Terminated

All 7 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
7